ELAVL1 and neoplasm: Given the plethora of tumor related genes targeted by HuR, it is plausible that in addition to interfering with tumor cell mitosis, an inhibition of post-transcriptional HuR regulons may essentially contribute to the potent antitumorigenic activity of clinically established microtubule inhibitors.